학술논문
Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain
Document Type
Article
Source
In: Health Economics Review . (Health Economics Review, 1 December 2017, 7(1))
Subject
Language
English
ISSN
21911991